What is the market doing?
What the tape says about NKTR
Nektar Therapeutics is +240% over the past year while the S&P 500 is +23%: 217 points ahead of the market.
+240%
1-year return · S&P 500 +23%
- vs 200-day average
- +16%
vs 200-day average · a clear uptrend
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- −26%
Below its 52-week high
Details›
- Last close2026-08-26
- $73.85
- 1 monthS&P 500 +3.7%
- +6.4%
- 1 yearS&P 500 +23%
- +240%
- 5 yearsS&P 500 +87%
- −69%
- vs 50-day average$67.67
- +9.1%
- 52-week high
- $100.35
- 52-week low
- $22.47
- Annualised volatility
- 143%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$86K
| Year | Return |
|---|---|
| 2026 (year to date) | +75% |
| 2025 | +203% |
| 2024 | +66% |
| 2023 | −75% |
| 2022 | −83% |
| 2021 | −21% |
| 2020 | −21% |
| 2019 | −34% |
| 2018 | −45% |
| 2017 | +387% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +5.2% |
| Feb | 10 | 7 of 10 | +8.7% |
| Mar | 10 | 4 of 10 | −2.1% |
| Apr | 10 | 5 of 10 | +3.7% |
| May | 10 | 2 of 10 | −8.1% |
| Jun | 10 | 4 of 10 | +12% |
| Jul | 11 | 6 of 11 | +1.1% |
| Aug | 11 | 5 of 11 | +1.9% |
| Sep | 10 | 5 of 10 | +8.1% |
| Oct | 10 | 3 of 10 | −8.9% |
| Nov | 10 | 6 of 10 | +9.9% |
| Dec | 10 | 5 of 10 | −3.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.